A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis

A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis

Abstract INTRODUCTION: The treatment of mucosal leishmaniasis (ML) is difficult due to the toxicity and route of administration of standard drugs. Miltefosine is an oral agent used for leishmaniasis treatment; however, no data exist regarding its use for ML in Brazil. In this study, we aimed to ev...

Full description

Bibliographic Details
Main Authors: Raimunda Nonata Ribeiro Sampaio, Juliana Saboia Fontenele e Silva, Carmen Dea Ribeiro de Paula, Cláudia Porto, Jorgeth de Oliveira Carneiro da Motta, Ledice Inacia de Araujo Pereira, Sofia Sales Martins, Daniel Holanda Barroso, Gustavo Subtil Magalhães Freire, Ciro Martins Gomes
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2019-03-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Leishmaniasis
Mucosal Leishmaniasis
Controlled Clinical Trial
Pentavalent antimonial
Therapeutics
Miltefosine.
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100315&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100315&lng=en&tlng=en

Similar Items